These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17172884

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The African American Heart Failure Trial: a clinical trial update.
    Taylor AL.
    Am J Cardiol; 2005 Oct 10; 96(7B):44-8. PubMed ID: 16226935
    [Abstract] [Full Text] [Related]

  • 24. Current perspectives on hydralazine and nitrate therapies in heart failure.
    Cole RT, Gupta D, Butler J.
    Heart Fail Clin; 2014 Oct 10; 10(4):565-76. PubMed ID: 25217432
    [Abstract] [Full Text] [Related]

  • 25. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.
    Khazanie P, Liang L, Curtis LH, Butler J, Eapen ZJ, Heidenreich PA, Bhatt DL, Peterson ED, Yancy CW, Fonarow GC, Hernandez AF.
    Circ Heart Fail; 2016 Feb 10; 9(2):e002444. PubMed ID: 26867758
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. BiDil for heart failure in black patients.
    Bibbins-Domingo K, Fernandez A.
    Ann Intern Med; 2007 Aug 07; 147(3):214-5; author reply 215-6. PubMed ID: 17679712
    [No Abstract] [Full Text] [Related]

  • 29. BiDil for heart failure in black patients.
    Kahn JD.
    Ann Intern Med; 2007 Aug 07; 147(3):215; author reply 215-6. PubMed ID: 17679713
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.
    Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN.
    J Am Coll Cardiol; 2007 Jan 02; 49(1):32-9. PubMed ID: 17207719
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.
    Franciosa JA.
    Expert Opin Pharmacother; 2006 Dec 02; 7(18):2521-31. PubMed ID: 17150006
    [Abstract] [Full Text] [Related]

  • 35. Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
    Yancy CW, Ghali JK, Braman VM, Sabolinski ML, Worcel M, Archambault WT, Franciosa JA.
    Am J Cardiol; 2007 Aug 15; 100(4):684-9. PubMed ID: 17697829
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial.
    Anand IS, Win S, Rector TS, Cohn JN, Taylor AL.
    Circ Heart Fail; 2014 Sep 15; 7(5):759-65. PubMed ID: 24970468
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Ziesche S, Cobb FR, Cohn JN, Johnson G, Tristani F.
    Circulation; 1993 Jun 15; 87(6 Suppl):VI56-64. PubMed ID: 8500241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.